Pipeline Moves: J&J ends ulcerative colitis trial, further study chances drop
Clinical Trials Arena reviews a total of six trials, including ones in gram-negative bacterial infections, hepatitis B, and obesity.
By
Homepage
Latest in
Homepage
Moderna eyes combined Covid-19, flu booster by 2023
Moderna CEO Stéphane Bancel also said an Omicron-specific Covid-19 vaccine will enter clinical development in a matter of weeks.
By
Mapping Endpoints: How to build an ALS clinical trial
Differing endpoint and efficacy expectations can make designing an ALS clinical trial challenging. Clinical Trials Arena looks at ways to…
By
Pipeline Moves: GSK’s likelihood of further study in tuberculosis rises
Stuart Therapeutics in dry eye disease and Vifor Pharma in beta thalassemia are also reviewed by Clinical Trials Arena.
By
ALS: drug trial results to watch in 2022
Pharma companies are pouring more efforts into ALS studies, setting the stage for several major drug trial readouts this year.
By